HUNTINGDON LIFE SCIENCES GROUP PLC

Huntingdon Life Sciences Group PLC operates as a global provider of preclinical laboratory services, offering toxicology, pharmacology, and pathology insights tailored to the needs of pharmaceutical developers, specialty chemical manufacturers, and agrochemical innovators that require compliant safety data for regulatory submissions. The company builds on its Services-Engineering Services roots (SIC 8734 Testing Laboratories) to deliver integrated study design, GLP documentation, and data reporting, while also helping clients navigate product stewardship expectations across markets. Through partnerships and in-house animal models, it furnishes the kind of reproducible datasets buyers expect for NDA, IND, and REACH dossiers, yet it must balance that work against increasingly vocal animal welfare scrutiny, evolving EU and U.S. oversight, and the reputational risks tied to protest activity and changing sustainability mandates. Investors therefore watch filings such as the Form 8-K from November 1999 for any updates on executive shifts, litigation, or compliance matters. CIK 718083 encapsulates the company in SEC records; view live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025